Podcasts about laboratory head

What connects beetles, Leonardo Di Caprio, hotspots and the youth? In this Hopeful Globe podcast episode, Dr. Emmanuel D. Delocado from Ateneo de Manila University in the Philippines explains how biodiversity conservation and education are the answer to this question. Dr. Delocado discusses the topical issue of biodiversity in the Philippines and the Southeast Asia region with Pilvi Posio from the university of Turku. The episode introduces the concepts of reconciliation ecology, biodiversity hotspots while also discussing the challenges in promoting biodiversity conservation and education in Southeast Asia, as well as its future prospects. Pilvi Posio is a senior researcher at the university of Turku in a project Finnish-ASEAN Academic Platform for Sustainable Development, run by the Finnish University Network for Asian Studies https://www.asianet.fi/projects/ Emmanuel D. Delocado is an assistant professor at the Department of Biology of the Ateneo de Manila University in the Philippines and the Laboratory Head of the Ateneo Biodiversity Research Laboratory. He's the Program Manager for Sustainable Development Goals of the Ateneo Institute of Sustainability, the Executive Director of ASEAN University Network on Ecological Education and Culture and the Country Manager of Sustainable Development Solutions Network Philippines. Learn more about activities developing biodiversity education and conservation at the Ateneo de Manila University here: Beetle discovery named after Philippine Vice President https://www.ateneo.edu/news/2022/07/14/angat-buhay-beetle-discovered-using-innovative-lab-home-set BIO-PHIL project of the Ateneo Biodiversity Research Laboratory -https://www.ateneo.edu/news/2022/12/14/biodiversity-lab-concludes-bio-phil-project-back-back-collaborative-workshop Roundtable discussion on teaching biodiversity https://www.ateneo.edu/news/2023/01/16/aun-eec-biodiv-lab-bio-phil-psfs-partnered-roundtable-discussion-teaching Transcript of the episode can be found here: www.utu.fi/fi/ajankohtaista/podcast/hopeful-globe

Welcome to Neurocareers, the podcast that proves the impossible is possible! We're thrilled to bring you the second episode of our BCI Award Neurocareers series featuring Prof. Nicholas Opie, the mastermind behind the revolutionary Stentrode and endovascular neural interfaces. Prof. Opie, a biomedical engineer and the founding CTO of Synchron, knows what it takes to succeed in the innovative field of neurotech. Prof. Opie's Stentrode project won 1st place in the International BCI Award competition in 2021. In this podcast episode, he'll share his top tips for winning the International BCI Award and building a successful career in the industry. Join us as we dive deep into the Stentrode revolution and discover how endovascular neural interfaces are changing the game. Prof. Opie will take us through his groundbreaking research and share insights on making the impossible possible in neurotech. As always, Neurocareers inspires and educates you on the exciting and ever-evolving world of neuroscience and neurotechnologies. Don't miss this opportunity to learn from one of the best in the field! This BCI Award Neurocareers series is a partnership between Milena Korostenskaja, PhD at the Institute of Neuroapproaches, and Christoph Guger, PhD at g.tec biomedical engineering. About the Podcast Guest: Professor Nicholas Opie, BE BSc PhD MBA, is a leading biomedical engineer and an expert in neural interfaces. He currently serves as the Laboratory Head of the Vascular Bionics Laboratory in the Department of Medicine at the University of Melbourne, where he is also an NHMRC Research Fellow. Throughout his career, Prof Opie has brought multiple biomedical devices from concept to clinic, including a suprachoroidal retinal prosthesis (bionic eye) that aims to restore vision to individuals with profound vision loss, and a motor neuron prosthesis (bionic spine) that seeks to restore independence, communication, and mobility to individuals with paralysis. He has published over 55 peer-reviewed journal articles, including in Nature Biomedical Engineering and Nature Biotechnology. Additionally, he has filed over 90 patents and was awarded the 2021 NFMRI John Raftos AM Award for Advancing Innovation. Prof Opie is also Synchron's founding Chief Technology Officer (CTO), a neural interface company based in Melbourne and New York. He has raised over AUD$210M in private funding and grants and designed Synchron's flagship product, the Stentrode™. The Stentrode is listed in Time Magazine's Top 100 Inventions of 2021 and aims to provide treatment for debilitating medical illnesses while empowering patients by reconnecting them online in ways that dramatically improve their lives. Following a successful first-in-human trial conducted in Australia on the Stentrode motor neuroprosthesis, Prof Opie and Synchron recently received approval from the US FDA. This approval paves the way for a trial in the US, which will commence this year and represents a significant step towards the first FDA approval for implantable brain-computer interfaces. To learn more about Prof Opie and his work, visit his profile page at the University of Melbourne: https://findanexpert.unimelb.edu.au/profile/430403-nicholas-opie. You can also check out the Stentrode SWITCH study, which involved four patients: https://pubmed.ncbi.nlm.nih.gov/36622685/. Learn more about Synchron's innovative technology on their website: https://synchron.com/. Finally, connect with Prof Nicholas Opie on LinkedIn: https://www.linkedin.com/in/professor-nicholas-opie-4603289a/. About the podcast host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for students and recent graduates in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities facing students in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news  

In this interview, AHRI's Jessica Strauss chats with Dr Aimone Porri, who is the Laboratory Head for Herbicide Target and Weed Resistance Research at BASF, based in Germany. Aimone's work spans across several fields in the weeds resistance research space, including working as a Geneticist, Molecular Biologist, and Plant Biologist. At the time of this chat, he was  in Australia visiting AHRI. Aimone has collaborated with AHRI for several years. We talk about some of the significant work he has done, including , working on pyroxasulfone resistance in ryegrass, as well as work on cinmethylin and multiple herbicide resistant ryegrass. We also chat about his current work in the weed resistance space, including his current paper on PPO mutations.  You can follow Aimone on Twitter here. You can follow AHRI on Twitter here. To learn more about AHRI's research and team, check out the website here.

Dr. Laura Mackay is a Professor and Laboratory Head at the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. She talks about her tissue-resident memory T cell research and her ongoing collaboration with Pfizer to identify and validate new targets for cancer therapy.

Tuberculosis is the world's longest-running pandemic and kills about two million world citizens a year. While often it is the immune response to bacterial infection that's so dangerous, tuberculosis adds a complexity that is especially challenging. Anna Coussens zeros in on several of these complexities in her research. Listen in and learn How the immune response differs dramatically among those infected and how Dr. Coussens is trying to understand why, What is the disease progression and ways the immune response harms the infected individual, and How she is working on "host-directed therapy" as a way to combat the complexities of the disease. Anna Coussens is a Laboratory Head in the Division of Infectious Diseases and Immune Defense with the Walter and Eliza Hall Institute of Medical Research. Her work in infectious diseases microbiology focuses specifically on tuberculosis as an immunologist. Because TB is a dominant problem in lower socioeconomic countries, it is often forgotten about in other areas. This has pushed treatment down on the list of common infectious diseases, but Dr. Coussens is working to change this.  She helps listeners understand why Mycobacterium tuberculosis is still the cause of so much illness, explaining the interplay of immunity and infection. It can trick T-cells into not recognizing its presence in infected cells through an extra-cellular vesicle sleight of hand. Furthermore, it has a very slow growth pattern, which makes it both hard to treat and hard to study in lab conditions. Many infected persons can exhibit a strong response and inflammation for years before doctors can detect bacteria in their sputum. Dr. Coussens is trying to understand why different cells can react in such varied ways to the bacteria. Her research aims to find a way to treat the individual and the immune dysfunction of that individual through "host-directed therapy." She hopes to help resolve inflammation that might lead to better outcomes for treatment. People who have had TB are actually at a high risk for getting it again, which perpetuates the disease in high-burden areas. Listen as one researcher describes her hard work to bring better treatment to these communities. For more about her work, follow her on Twitter as @AnnaCoussens and see her web page at WEHI. Available on Apple Podcasts: apple.co/2Os0myK

Dr Shane, Dr Linden, Dr Krystal discuss changing blood types and genetic engineering in human embryos.The team talk with Dr Januka Attanayake from the University of Melbourne, about research into the relationships between neighbouring earthquakes. Read more They also chat to Dr Yugeesh R. Lankadeva, Ph.D., who is the Laboratory Head, Translational Cardiovascular and Renal Research Group, National Heart Foundation Future Leader Research Fellow, Co-Chair, Florey Mentoring Committee, Discovery Science Theme with the Florey Institute of Neuroscience and Mental Health; who explains the latest findings in the understanding of the best ways to approach cardiac bypass surgery.Remember, “Science is everywhere”, including:Program page: Einstein-A-Go-GoFacebook page: Einstein-A-Go-GoTwitter: Einstein-A-Go-Goand every Sunday at 11:00am AEST on RRR 102.7 FM.

Dr Laura and Dr Ray join Dr Shane in the studio. In news, mosquitos dont like AC/DC, reverse snowflakes and the first ever photograph of a black hole.First guest 1 isDr Pam Rana,presenting Kim Kardashian Breaks the Environment: Keeping up with climate change! The doctor dissects how our global ecological crisis is directly related to Kim Kardashians' existence. It's a funny inconvenient truth but the main cause of rising sea levels is reality TV stars. Second guest is Dr Tye-Din,Laboratory Head at the Walter and Eliza Hall Institute (WEHI) andMathison Centenary Fellow at the University of Melbourne. It is estimated that although 1.5 per cent of Australians are affected by coeliac disease, around 80 percent remain undetected and undiagnosed. Coeliac patients have an immune intolerance to gluten something the body should tolerate is treated as a threat. The aim of Dr Tye-Dins PhD research was to define all of the toxic peptides in wheat, rye, barley and oats find the most important ones that could be used in a therapeutic vaccine to retrain a patients immune system to tolerate gluten.

Over the Australian summer, we'll be replaying some of your favourite episodes. We bet you will learn something you missed the first time. Dr Melissa Davis is a computational biologist and Laboratory Head of the Bioinformatics Division at the Walter and Eliza Hall Institute. Driven by a passion to make the cancer diagnosis a less devastating one, Melissa and her team are at the cutting edge of bioinformatic studies aimed to reduce the traumatic side effects patients experience while being treated for cancer.In this week's Success Story, Melissa shares with Catherine Robson the role sophisticated data analytics and mathematical modelling play in revolutionising cancer treatment and why a difficult financial decision led to the career she loves today.

In this week’s Success Story, Professor Gabrielle Belz, an award-winning scientist and Laboratory Head of the Molecular Immunology division at The Walter and Eliza Hall Institute of Medical Research (WEHI) explains to Catherine Robson the importance of nurturing a healthy gut, shares career advice for young scientists and her productivity hacks for managing the ‘reasonably unreasonable’ time demands of a career in science.

Dr Melissa Davis is a computational biologist and  Laboratory Head of the Bioinformatics Division at the  Walter and Eliza Hall Institute. Driven by a passion to make the cancer diagnosis a less devastating one, Melissa and her team are at the cutting edge of bioinformatic studies aimed to reduce the traumatic side effects patients experience while being treated for cancer. In this week's Success Story, Melissa shares with Catherine Robson the role sophisticated data analytics and mathematical modelling play in revolutionising cancer treatment and why a difficult financial decision led to the career she loves today.

Patrizia Longone, Laboratory Head, Fondazione Santa Lucia - Molecular Neurobiology, Rome - ITALY speaks on "Activity-dependent expression of heterogeneous nuclear ribonucleoprotein (hnRNP) mRNAs in neurons: regulated translation at the synapse - RNA Metabolism: Changing Paradigms in Neurodegeneration” This seminar has been recorded at Area Science Park Trieste by ICGEB Trieste

This week on Neurotalk, Nelson Spruston describes some of the first patch clamp recordings ever, shares the most exciting moment of his scientific career, and explains how a student in his lab discovered a new form of neural integration. Dr. Spruston is the Scientific Program Director, and a Laboratory Head at the Howard Hughes Medical Institute at the Janelia Farm Research Campus.

Interview with Dr John Dixon. Dr Dixon is the Laboratory Head of Clinical Obesity Research at the Baker IDI Heart and Diabetes Institute, Associate Professor and Head of the Obesity Research Unit, and the Obesity Assessment and Management Clinic at the School of Primary Health Care at Monash University, in Melbourne, Australia. During this interview our […]